S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 02:21 AM ET

NUWE

Nuwellis, Inc.

Price Chart

No historical data available

Latest Quote

$2.85

-0.09 (-3.06%)
Current Price
Previous Close $2.94
Open $2.90
Day High $2.97
Day Low $2.77
Volume 37,057
Fetched: 2026-07-17T22:20:10
Stock Information
Shares Outstanding 92K
Total Debt $265K
Cash Equivalents $2.08M
Revenue $8.77M
Net Income $-19.04M
Sector Healthcare
Industry Medical Devices
Market Cap $263K
P/E Ratio 0.06
EPS (TTM) $47.25
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Nuwellis, Inc.

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $3,146,000 $3,064,000 $3,881,000 $3,788,000
Cost Of Revenue $3,146,000 $3,064,000 $3,881,000 $3,788,000
Total Revenue $8,270,000 $8,740,000 $8,864,000 $8,543,000
Operating Revenue $8,270,000 $8,740,000 $8,864,000 $8,543,000
Expenses
Interest Expense $10,553,000 $5,607,000 $3,483,000 $9,247,000
Total Expenses $19,376,000 $19,728,000 $26,494,000 $25,714,000
Other Income Expense $4,143,000 $5,435,000 $912,000 $11,902,000
Other Non Operating Income Expenses $10,000 $-80,000 $154,000 $75,000
Net Non Operating Interest Income Expense $-10,553,000 $-5,607,000 $-3,483,000 $-9,247,000
Interest Expense Non Operating $10,553,000 $5,607,000 $3,483,000 $9,247,000
Operating Expense $16,230,000 $16,664,000 $22,613,000 $21,926,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-17,521,000 $-11,165,000 $-20,209,000 $-14,525,000
Net Interest Income $-10,553,000 $-5,607,000 $-3,483,000 $-9,247,000
Normalized Income $-20,786,070 $-15,521,850 $-20,807,820 $-23,868,330
Net Income From Continuing And Discontinued Operation $-17,521,000 $-11,165,000 $-20,209,000 $-14,525,000
Total Operating Income As Reported $-11,106,000 $-10,988,000 $-17,630,000 $-17,171,000
Net Income Common Stockholders $-17,517,000 $-10,624,000 $-22,627,000 $-14,525,000
Net Income $-17,521,000 $-11,165,000 $-20,209,000 $-14,525,000
Net Income Including Noncontrolling Interests $-17,521,000 $-11,165,000 $-20,209,000 $-14,525,000
Net Income Continuous Operations $-17,521,000 $-11,165,000 $-20,209,000 $-14,525,000
Pretax Income $-17,516,000 $-11,160,000 $-20,201,000 $-14,516,000
Special Income Charges $0 $900,000 $0 -
Operating Income $-11,106,000 $-10,988,000 $-17,630,000 $-17,171,000
Gross Profit $5,124,000 $5,676,000 $4,983,000 $4,755,000
Per Share
Diluted EPS $-888.65 $-3571.09 $-16934.40 $-947.80
Basic EPS $-888.65 $-3571.09 $-16934.40 $-947.80
Other
Tax Effect Of Unusual Items $867,930 $1,158,150 $159,180 $2,483,670
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-10,679,000 $-10,758,000 $-17,114,000 $-16,724,000
Total Unusual Items $4,133,000 $5,515,000 $758,000 $11,827,000
Total Unusual Items Excluding Goodwill $4,133,000 $5,515,000 $758,000 $11,827,000
Reconciled Depreciation $417,000 $310,000 $362,000 $372,000
EBITDA (Bullshit earnings) $-6,546,000 $-5,243,000 $-16,356,000 $-4,897,000
EBIT $-6,963,000 $-5,553,000 $-16,718,000 $-5,269,000
Diluted Average Shares $19,718 $2,975 $110 $10
Basic Average Shares $19,718 $2,975 $110 $10
Diluted NI Availto Com Stockholders $-17,517,000 $-10,624,000 $-22,627,000 $-14,525,000
Preferred Stock Dividends $-4,000 $-541,000 $2,418,000 -
Tax Provision $5,000 $5,000 $8,000 $9,000
Gain On Sale Of Security $4,133,000 $4,615,000 $758,000 $11,827,000
Research And Development $2,712,000 $3,209,000 $5,422,000 $4,342,000
Selling General And Administration $13,518,000 $13,455,000 $17,191,000 $17,584,000
Other Special Charges - $-900,000 - -
Fetched: 2026-07-08
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $2,630,000 $6,530,000 $3,211,000 $12,357,000
Total Assets $6,118,000 $9,864,000 $9,770,000 $24,673,000
Total Non Current Assets $932,000 $1,009,000 $1,561,000 $1,904,000
Other Non Current Assets $271,000 $21,000 $120,000 $21,000
Current Assets $5,186,000 $8,855,000 $8,209,000 $22,769,000
Other Current Assets $698,000 $315,000 $461,000 $396,000
Inventory $1,910,000 $1,718,000 $1,997,000 $2,661,000
Receivables $1,493,000 $1,727,000 $1,951,000 $1,406,000
Accounts Receivable $1,493,000 $1,727,000 $1,951,000 $1,406,000
Cash Cash Equivalents And Short Term Investments $1,085,000 $5,095,000 $3,800,000 $18,306,000
Cash And Cash Equivalents $1,085,000 $5,095,000 $3,800,000 $17,737,000
Debt
Total Debt $328,000 $545,000 $760,000 $984,000
Long Term Debt And Capital Lease Obligation $67,000 $307,000 $544,000 $760,000
Current Debt And Capital Lease Obligation $261,000 $238,000 $216,000 $224,000
Liabilities
Total Liabilities Net Minority Interest $3,488,000 $3,334,000 $6,559,000 $12,316,000
Total Non Current Liabilities Net Minority Interest $456,000 $775,000 $3,387,000 $7,628,000
Derivative Product Liabilities $389,000 $468,000 $2,843,000 $6,868,000
Current Liabilities $3,032,000 $2,559,000 $3,172,000 $4,688,000
Other Current Liabilities $85,000 $41,000 $51,000 $58,000
Payables And Accrued Expenses $2,226,000 $1,640,000 $2,380,000 $2,245,000
Payables $2,226,000 $1,640,000 $2,380,000 $2,245,000
Accounts Payable $2,226,000 $1,640,000 $2,380,000 $2,245,000
Other Non Current Liabilities - - - -
Equity
Common Stock Equity $2,624,000 $6,528,000 $2,990,000 $12,357,000
Preferred Stock Equity $6,000 $2,000 $221,000 -
Total Equity Gross Minority Interest $2,630,000 $6,530,000 $3,211,000 $12,357,000
Stockholders Equity $2,630,000 $6,530,000 $3,211,000 $12,357,000
Gains Losses Not Affecting Retained Earnings $8,000 $-47,000 $-31,000 $38,000
Retained Earnings $-316,312,000 $-298,791,000 $-287,626,000 $-267,417,000
Other Equity Adjustments - - - $56,000
Other
Ordinary Shares Number $48,177 $2,975 $110 $10
Share Issued $48,177 $2,975 $110 $10
Tangible Book Value $2,624,000 $6,528,000 $2,990,000 $12,357,000
Invested Capital $2,624,000 $6,528,000 $2,990,000 $12,357,000
Working Capital $2,154,000 $6,296,000 $5,037,000 $18,081,000
Capital Lease Obligations $328,000 $545,000 $760,000 $984,000
Total Capitalization $2,630,000 $6,530,000 $3,211,000 $12,357,000
Foreign Currency Translation Adjustments $8,000 $-47,000 $-31,000 $-18,000
Additional Paid In Capital $318,928,000 $305,366,000 $290,647,000 $279,736,000
Capital Stock $6,000 $2,000 $221,000 $0
Common Stock $0 $0 $0 $0
Preferred Stock $6,000 $2,000 $221,000 $0
Long Term Capital Lease Obligation $67,000 $307,000 $544,000 $760,000
Current Capital Lease Obligation $261,000 $238,000 $216,000 $224,000
Pensionand Other Post Retirement Benefit Plans Current $460,000 $640,000 $525,000 $2,161,000
Net PPE $661,000 $988,000 $1,441,000 $1,883,000
Accumulated Depreciation $-3,978,000 $-3,778,000 $-3,482,000 $-3,171,000
Gross PPE $4,639,000 $4,766,000 $4,923,000 $5,054,000
Leases $253,000 $253,000 $253,000 $253,000
Other Properties $3,314,000 $3,446,000 $3,607,000 $3,707,000
Machinery Furniture Equipment $1,072,000 $1,067,000 $1,063,000 $1,094,000
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-80,000 $-235,000 $-75,000 $-145,000
Finished Goods $445,000 $512,000 $393,000 $993,000
Work In Process $88,000 $131,000 $207,000 $204,000
Raw Materials $1,457,000 $1,310,000 $1,472,000 $1,609,000
Other Short Term Investments - - $0 $569,000
Unrealized Gain Loss - - - $56,000
Fetched: 2026-07-08
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-10,900,000 $-9,651,000 $-18,185,000 $-15,271,000
Operating Activities
Operating Cash Flow $-10,810,000 $-9,591,000 $-17,937,000 $-15,149,000
Cash Flow From Continuing Operating Activities $-10,810,000 $-9,591,000 $-17,937,000 $-15,149,000
Operating Gains Losses $-4,133,000 $-4,516,000 $-823,000 $-11,703,000
Investing Activities
Capital Expenditure $-90,000 $-60,000 $-248,000 $-122,000
Investing Cash Flow $-90,000 $-60,000 $330,000 $14,728,000
Cash Flow From Continuing Investing Activities $-90,000 $-60,000 $330,000 $14,728,000
Financing Activities
Issuance Of Capital Stock $6,940,000 $8,428,000 $3,591,000 $9,449,000
Financing Cash Flow $6,940,000 $10,962,000 $3,683,000 $9,423,000
Cash Flow From Continuing Financing Activities $6,940,000 $10,962,000 $3,683,000 $9,423,000
Net Preferred Stock Issuance $0 $501,000 $1,482,000 $0
Preferred Stock Issuance $0 $501,000 $1,482,000 $0
Net Common Stock Issuance $6,940,000 $7,927,000 $2,109,000 $9,449,000
Common Stock Issuance $6,940,000 $7,927,000 $2,109,000 $9,449,000
Other
Income Tax Paid Supplemental Data $7,000 $7,000 $12,000 $9,000
End Cash Position $1,190,000 $5,095,000 $3,800,000 $17,737,000
Beginning Cash Position $5,095,000 $3,800,000 $17,737,000 $8,742,000
Effect Of Exchange Rate Changes $55,000 $-16,000 $-13,000 $-7,000
Changes In Cash $-3,960,000 $1,311,000 $-13,924,000 $9,002,000
Proceeds From Stock Option Exercised $0 $2,534,000 $120,000 $0
Net PPE Purchase And Sale $-90,000 $-60,000 $-149,000 $-122,000
Purchase Of PPE $-90,000 $-60,000 $-149,000 $-122,000
Change In Working Capital $-253,000 $-305,000 $-1,420,000 $598,000
Change In Other Working Capital $-173,000 $-22,000 $-7,000 $-96,000
Change In Other Current Assets $-528,000 $-160,000 $-65,000 $-68,000
Change In Payables And Accrued Expense $406,000 $-626,000 $-1,500,000 $1,278,000
Change In Inventory $-192,000 $279,000 $697,000 $140,000
Change In Receivables $234,000 $224,000 $-545,000 $-656,000
Changes In Account Receivables $234,000 $224,000 $-545,000 $-656,000
Other Non Cash Items $10,553,000 $5,607,000 $3,483,000 $9,247,000
Stock Based Compensation $127,000 $478,000 $670,000 $862,000
Depreciation Amortization Depletion $417,000 $310,000 $362,000 $372,000
Depreciation And Amortization $417,000 $310,000 $362,000 $372,000
Depreciation $417,000 $310,000 - -
Gain Loss On Investment Securities $-4,133,000 $-4,615,000 $-823,000 $-11,703,000
Gain Loss On Sale Of PPE $0 $99,000 $0 -
Net Income From Continuing Operations $-17,521,000 $-11,165,000 $-20,209,000 $-14,525,000
Repayment Of Debt - $0 $-28,000 $-26,000
Net Issuance Payments Of Debt - $0 $-28,000 $-26,000
Net Long Term Debt Issuance - $0 $-28,000 $-26,000
Long Term Debt Payments - $0 $-28,000 $-26,000
Net Investment Purchase And Sale - $0 $578,000 $14,850,000
Sale Of Investment - $0 $578,000 $14,850,000
Net Intangibles Purchase And Sale - $0 $-99,000 $0
Purchase Of Intangibles - $0 $-99,000 $0
Purchase Of Investment - - - $0
Sale Of PPE - - - -
Net Foreign Currency Exchange Gain Loss - - - -
Fetched: 2026-07-08